Ono Pharma Foundation carries out the Ono Pharma Breakthrough Science Initiative Awards Program (“Ono Initiative”), a competitive awards program to support scientific research projects throughout the United States. Ono initiative is the embodiment of our commitment to accelerate open innovation by supporting high-risk and high-reward science research projects, which have potential to lead to science discoveries/solutions and, possible, based on further research, to breakthrough treatments for patients.
Accelerating Open Innovation,
Changing Human Health Care.
Annually, the Ono Pharma Foundation will consider proposals from Principal Investigators (PIs) for research that could ultimately transform human health. Applications comprising laboratory investigation will be considered. Project duration may last up to three years with annual funding for the normal term of a research project.
Three Awards are planned for the fifth year (2021). It is expected that funds will be available in subsequent years, but the funding and the amounts will be dependent on annual appropriations.